158 related articles for article (PubMed ID: 9513901)
21. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
22. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors.
Sudo H; Hirata M; Kanada H; Yorozu K; Tashiro Y; Serizawa K; Yogo K; Kataoka M; Moriguchi Y; Ishizuka N
J Pharmacol Sci; 2009 Sep; 111(1):53-9. PubMed ID: 19721333
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
24. Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides. Evidence for an anti-inflammatory role for nucleotidases.
Poelstra K; Heynen ER; Baller JF; Hardonk MJ; Bakker WW
Lab Invest; 1992 May; 66(5):555-63. PubMed ID: 1533430
[TBL] [Abstract][Full Text] [Related]
25. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
26. Effect of a matrix metalloproteinase inhibitor (BB-1101) on nerve regeneration.
Demestre M; Gregson NA; Smith KJ; Miller KM; Gearing AJ; Hughes RA
Ann N Y Acad Sci; 1999 Jun; 878():658-61. PubMed ID: 10415800
[No Abstract] [Full Text] [Related]
27. The role of matrix metalloproteinases in the activation of mesangial cells.
Marti HP
Transpl Immunol; 2002 May; 9(2-4):97-100. PubMed ID: 12180853
[TBL] [Abstract][Full Text] [Related]
28. Adenosine 3', 5' cyclic monophosphate attenuates the production of fibronectin in the glomeruli of anti-glomerular basement membrane antibody-associated nephritic rats.
Nagamatsu T; Nishiyama T; Goto I; Nagao T; Suzuki Y
Br J Pharmacol; 2003 Dec; 140(7):1245-51. PubMed ID: 14597604
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis.
Hayashi K; Osada S; Shofuda K; Horikoshi S; Shirato I; Tomino Y
J Am Soc Nephrol; 1998 Dec; 9(12):2262-71. PubMed ID: 9848780
[TBL] [Abstract][Full Text] [Related]
31. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
32. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
33. Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation.
Steinmann-Niggli K; Lukes M; Marti HP
J Am Soc Nephrol; 1997 Mar; 8(3):395-405. PubMed ID: 9071708
[TBL] [Abstract][Full Text] [Related]
34. Post-inflammatory glomerular remodeling is influenced by transformed mesangial cells.
Zhang LS; Aoyagi D; Nakazawa K; Otani M
Pathol Int; 2005 Apr; 55(4):189-201. PubMed ID: 15826245
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
Rosenberg GA; Estrada EY; Dencoff JE
Stroke; 1998 Oct; 29(10):2189-95. PubMed ID: 9756602
[TBL] [Abstract][Full Text] [Related]
36. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
37. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
38. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.
Matyszak MK; Perry VH
J Neuroimmunol; 1996 Sep; 69(1-2):141-9. PubMed ID: 8823386
[TBL] [Abstract][Full Text] [Related]
39. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
40. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
